SCHEMBL14327768

SCHEMBL14327768

Oc1ccc(-c2ccccc2)cc1-c1cc2ccccc2c(-c2c(O)c(-c3cc(-c4ccccc4)ccc3O)cc3ccccc23)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 4/20 0.55
▸ HSD17B2 P37059 4/20 0.55
▸ ESR2 Q92731 3/20 0.51
▸ ESR1 P03372 2/20 0.51
▸ ALOX5 P09917 3/20 0.50
▸ GPR84 Q9NQS5 5/20 0.48
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2B6 P20813 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MPI P34949 1/20 0.44
▸ USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14327802 0.89 ALOX5 (0.51) HSD17B1HSD17B2ESR2ESR1ALOX5
SCHEMBL14327794 0.85 MCL1 (0.54) HSD17B1HSD17B2ALOX5GPR84CYP1A2
SCHEMBL14327785 0.84 GPR84 (0.50) HSD17B1HSD17B2ESR2ESR1ALOX5
SCHEMBL29510114 0.81 MEN1 (0.58) HSD17B1HSD17B2ALOX5GPR84MEN1
SCHEMBL3262604 0.81 MEN1 (0.58) HSD17B1HSD17B2ALOX5GPR84MEN1
SCHEMBL30275493 0.81 MEN1 (0.58) HSD17B1HSD17B2ALOX5GPR84MEN1
SCHEMBL12786270 0.80 NQO1 (0.46) HSD17B1HSD17B2ESR2ALOX5GPR84
SCHEMBL29026237 0.79 MEN1 (0.52) HSD17B1HSD17B2ESR2ESR1ALOX5
SCHEMBL14327803 0.79 MEN1 (0.48) ALOX5GPR84CYP1A2MEN1KMT2A
SCHEMBL24434313 0.79 ALOX5 (0.70) HSD17B1HSD17B2ESR2ESR1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420847-B2 Bis-phosphate compound and asymmetric reaction using the same NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) 2013-04-16 — — US disclosed
US-8420847-B2 Bis-phosphate compound and asymmetric reaction using the same NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) 2013-04-16 — — US disclosed
US-20120330038-A1 BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME API CORPORATION (JP) 2012-12-27 — — US disclosed
US-20120330038-A1 BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME API CORPORATION (JP) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120330038-A1 BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME AASDHPPT, ALDH7A1, ATIC HSD17B1 962/4885HSD17B2 1377/4885ESR2 2316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback